Results 61 to 70 of about 11,206 (161)

Trust Norms, Distrust, and Worst‐Case Defiance in the COVID‐19 Pandemic

Regulation &Governance, Volume 20, Issue 3, Page 877-893, July 2026.
ABSTRACT When pandemics threaten, governments are expected to protect citizens. Trustworthiness and trust are central to meeting public expectations. Motivational posturing theory differentiates resistant and dismissive defiance during the COVID‐19 pandemic.
Valerie Braithwaite
wiley   +1 more source

An epidemiological investigation of the 2019 suspected pertussis outbreak in northwestern Nigeria

SAGE Open Medicine, 2021
Introduction: In 2019, we investigated the profile of the cases and controls and the determinants of pertussis transmission in Kebbi State, Northwestern Nigeria, to inform better immunization and surveillance strategies.
Omoleke Semeeh, Biniam Getachew, Yusuf Taofik, Lukman Surajudeen, Assad Hassan, Bello Nagudale   +5 more
doaj   +1 more source

A Protocol of National Mixed‐Methods Assessment of Childhood and Maternal Immunization

Health Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims Accurate measurement of routine immunization coverage is essential for detecting immunity gaps, guiding programmatic responses, and supporting equitable vaccine delivery. Iran's Expanded Programme on Immunization has achieved high coverage, but administrative estimates can mask some disparities.
Seyed Aria Nejadghaderi, Paria Dehesh, Mehran Nakhaeizadeh, Mohammadreza Rajabalipour, Faeze Tahrudi, Naser Nasiri, Seyed Mohsen Zahraei, Hamid Sharifi, AliAkbar Haghdoost   +8 more
wiley   +1 more source

Safety Surveillance of Diphtheria and Tetanus Toxoids and Acellular Pertussis (DTaP) Vaccines [PDF]

Pediatrics, 2018
OBJECTIVE:To assess the safety of currently licensed diphtheria-tetanus-acellular pertussis (DTaP) vaccines in the United States by using data from the Vaccine Adverse Event Reporting System (VAERS), a spontaneous reporting surveillance system.METHODS:We searched VAERS for US reports of DTaP vaccinations occurring from January 1, 1991, through December
Pedro L, Moro, Silvia, Perez-Vilar, Paige, Lewis, Marthe, Bryant-Genevier, Hajime, Kamiya, Maria, Cano   +5 more
openaire   +2 more sources

Leveraging large language models on free-text symptoms from participatory surveillance enhances pertussis forecasting in the United States

BMC Infectious Diseases
Background Declines in childhood vaccination in the U.S. have contributed to a resurgence of vaccine-preventable diseases, including a notable increase in pertussis cases. Traditional pertussis surveillance is limited by underdiagnosis and underreporting.
Luigi De Angelis, Samuele Tarallo, Caterina Rizzo, Autumn Gertz, Francesco Baglivo, John S. Brownstein, Benjamin Rader   +6 more
doaj   +1 more source

Emergence of Bordetella holmesii–Associated Pertussis-Like Illness, Northern India, 2019–2023

Emerging Infectious Diseases
We investigated Bordetella holmesii and Bordetella pertussis in 935 suspected pertussis cases in northern India (2019–2023) using PCR and serology. B. holmesii showed increased prevalence in pertussis cases, particularly in older children, highlighting ...
Nishant Shekhar, Deepa Sharma, Surajit Chakraborty, Rajesh Kumar, Rajneesh Singh Rawat, Nirmal Kaundal, Pawan Kumar, Tigran Avagyan, Deeksha Chauhan, Neha Jain, Megha Sharma, Arun Kumar, Vikas Gautam   +12 more
doaj   +1 more source

Understanding the Epidemiology of Pertussis in Denmark

Acta Paediatrica, EarlyView.
Tine Dalby, Aoife Ronayne, Peter Henrik Andersen   +2 more
wiley   +1 more source

Short‐Term Safety and Adverse Event Risk Profiles for SARS‐CoV‐2 Booster Vaccine Doses in Australian Adults: A Survey Study

Medical Journal of Australia, Volume 224, Issue 6, June 2026.
ABSTRACT Objective This study quantifies the short‐term risk profiles of seven severe acute respiratory syndrome coronavirus 2 virus (SARS‐CoV‐2) vaccines—Comirnaty Bivalent BA.1, Comirnaty Bivalent BA.4‐5, Comirnaty XBB.1.5, Spikevax Bivalent BA.1, Spikevax Bivalent BA.4‐5, Spikevax XBB.1.5 and Nuvaxovid—administered as booster doses in Australia ...
Evelyn Tay, Michael Dymock, Lucy Dawes, Lucy Deng, Thuy Nguyen, Alan Leeb, Julie A. Marsh, Nicholas Wood, Kristine Macartney, Thomas L. Snelling   +9 more
wiley   +1 more source

Antimicrobial susceptibilities of Bordetella species isolated in a Multicenter Pertussis Surveillance Project [PDF]

Antimicrobial Agents and Chemotherapy, 1988
MICs for 90% (MIC90s) of 75 Bordetella pertussis strains for amoxicillin, erythromycin, rifampin, and sulfamethoxazole-trimethoprim were 1, less than or equal to 0.12, 1, and 4 micrograms/ml, respectively. Susceptibility rates were all greater than or equal to 93%. Only 17% of the strains were susceptible to tetracycline.
T A, Kurzynski, D M, Boehm, J A, Rott-Petri, R F, Schell, P E, Allison   +4 more
openaire   +2 more sources

MODERNIZATION OF GENEOTIPING OF STRAINS B. PERTUSSIS

Детские инфекции (Москва), 2015
The new rapid molecular genotyping method was developed for studying the structure of ptxP promoter of pertussis toxin. Method is based on PCR-RFLP analysis, which allows studying the specific restriction profiles of the B.
G. A. Ivashinnikova, O. U. Borisova, A. V. Aleshkin, A. S. Pimenova, V. A. Aleshkin   +4 more
doaj   +1 more source